Precision BioSciences, Inc.DTILNASDAQ

Revenue (LTM)

$34M

-50.1% YoY

Net Income (LTM)

$-47M

-750.3% YoY

Free Cash Flow

$-66M

Revenue CAGR (5Y)

-26.2%

Marginsdeclining

FCF($0.1B)

Now unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	116	25↓78.3%	49↑94.1%	69↑41.0%	34↓50.1%
Gross Profit	116	25↓78.3%	49↑94.1%	69↑41.0%	32↓54.1%
Operating Income	-39	-62↓58.2%	-44↑29.8%	-26↑40.2%	-52↓99.3%
Net Income	-31	-112↓264.8%	-61↑45.1%	7↑111.7%	-47↓750.3%
EBITDA	-20	-63↓209.7%	-32↑49.0%	14↑142.2%	-49↓465.2%
EPS Diluted	-15.60	-38.10↓144.2%	-15.96↑58.1%	1.04↑106.5%	-3.63↓449.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	144	190↑32.0%	117↓38.5%	86↓26.4%	111↑29.0%
Total Current Assets	162	199↑23.1%	136↓31.5%	95↓30.3%	119↑25.0%
Total Assets	211	238↑12.6%	160↓32.9%	136↓14.6%	154↑13.2%
Total Current Liabilities	36	60↑65.8%	50↓16.2%	15↓70.0%	9↓40.5%
Total Liabilities	120	178↑47.7%	141↓20.7%	80↓43.2%	62↓22.3%
Total Equity	91	60↓33.7%	19↓68.8%	56↑199.0%	92↑63.6%
Total Debt	9	25↑173.9%	31↑25.3%	30↓3.9%	29↓4.1%
Net Debt	-135	-165↓22.3%	-85↑48.1%	-56↑34.6%	-82↓46.8%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-11	-46↓321.6%	-84↓83.8%	-58↑30.5%	-66↓12.7%
Capital Expenditure	-6	-3↑42.8%	-2↑31.4%	-0↑89.0%	-0↑66.0%
Free Cash Flow	-17	-49↓194.6%	-86↓76.1%	-59↑32.1%	-66↓12.3%
Stock-Based Comp	17	19↑16.2%	14↓26.9%	13↓10.2%	10↓19.2%
Net Change in Cash	54	46↓14.8%	-73↓258.8%	-8↑88.7%	29↑449.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance